Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential
Frontiers in Cellular and Infection Microbiology · 23.06.2023 · 13
DOI: 10.3389/fcimb.2023.1202138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 23.06.2023. Verfasst von Chuan Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Animal Diseases and Public Health Engineering Research Center of Henan Province, Luoyang Polytechnic, Luoyang, Henan, China. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Neoplasms. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Aerospace Science Foundation of China.
Abstract (Originalsprache)
Cancer is one of the leading causes of death worldwide. Human cytomegalovirus (HCMV), a well-studied herpesvirus, has been implicated in malignancies derived from breast, colorectal muscle, brain, and other cancers. Intricate host-virus interactions are responsible for the cascade of events that have the potential to result in the transformed phenotype of normal cells. The HCMV genome contains oncogenes that may initiate these types of cancers, and although the primary HCMV infection is usually asymptomatic, the virus remains in the body in a latent or persistent form. Viral reactivation causes severe health issues in immune-compromised individuals, including cancer patients, organ transplants, and AIDS patients. This review focuses on the immunologic mechanisms and molecular mechanisms of HCMV-induced carcinogenesis, methods of HCMV treatment, and other studies. Studies show that HCMV DNA and virus-specific antibodies are present in many types of cancers, implicating HCMV as an important player in cancer progression. Importantly, many clinical trials have been initiated to exploit HCMV as a therapeutic target for the treatment of cancer, particularly in immunotherapy strategies in the treatment of breast cancer and glioblastoma patients. Taken together, these findings support a link between HCMV infections and cellular growth that develops into cancer. More importantly, HCMV is the leading cause of birth defects in newborns, and infection with HCMV is responsible for abortions in pregnant women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Animal Diseases and Public Health Engineering Research Center of Henan Province, Luoyang Polytechnic, Luoyang, Henan, China.
- Department of Pharmaceutical Sciences, School of Basic Medical Sciences, Henan University of Science and Technology, Luoyang, Henan, China.
- School of Light Industry and Food Engineering, Nanjing Forestry University, Nanjing, Jiangsu, China.
- School of Arts and Science, Rutgers, the State University of New Jersey, Newark, NJ, United States.
Förderung
- National Aerospace Science Foundation of China
Zitieren
APA
Yu, C., He, S., Zhu, W., Ru, P., Ge, X., & Govindasamy, K. (2023). Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1202138
Vancouver
Yu C, He S, Zhu W, Ru P, Ge X, Govindasamy K. Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1202138
BibTeX
@article{Yu2023,
author = {Yu, Chuan and He, Suna and Zhu, Wenwen and Ru, Penghui and Ge, Xuemei and Govindasamy, Kavitha},
title = {Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1202138}
}
EUVIMED